After coronavirus vaccine breakthrough, mRNA pioneers pivot

BioNTech and Moderna lead the field, but there’s work to do to prove these new cancer vaccines are effective and would offer value to health systems.

Related Keywords

Germany , Poland , United Kingdom , France , Romania , Britain , Amgen Imlygic , Merck Kga , Orbimed Zaks , Fabrice Andr , Sam Godfrey , Uk National Health Service , Cancer Research , European Cancer Organization , European Medicines Agency , Gustave Roussy Cancer Center , Health Technology Assessment , Silent Killers , Tal Zaks , Translate Bio , Matti Aapro , Health Service , Cancer Plan , Cancer , Coronavirus , Drug And Device Safety , Health Care , Health Systems , Medicines , Oncology , Özlem Türeci , Patients , Pharma , Regulation , Research And Development , Vaccines ,